Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Arginyl-tRNA synthetase 1 pseudogene 1 (RARS1P1) is a processed pseudogene related to the arginyl-tRNA synthetase 1 (RARS1) gene. Pseudogenes are non-functional segments of DNA that resemble known genes but typically lack protein-coding potential due to acquired mutations or defects in regulatory elements. While some pseudogenes transcribe RNA that may impact biological processes through regulatory mechanisms (e.g., acting as decoys for microRNAs or regulators of parent gene expression), there is no evidence that RARS1P1 encodes a protein, acts as an enzyme, receptor, or other typical therapeutic target, or is relevant to small molecule or biologic drug action. Its biological and clinical significance remains unclear, except as a component of the genomic landscape and potential gene regulation influences typically ascribed to pseudogenes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Arginyl-tRNA synthetase 1 pseudogene 1 (RARS1P1).